Tirzepatide
Showing 51 - 58 of 58
Healthy Trial in Dallas (Tirzepatide, Placebo)
Completed
- Healthy
- Tirzepatide
- Placebo
-
Dallas, TexasCovance
Jan 31, 2019
Testing the Effectiveness of WW + Sequence GLP1 (WW+Sequence)
Enrolling by invitation
- Weight Loss
- Obesity
-
Cleveland, OhioCleveland Clinic
Sep 5, 2023
Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists
Not yet recruiting
- Gastric Ultrasound
- +2 more
- Gastric Ultrasound Exam
- (no location specified)
Aug 15, 2023
Type 2 Diabetes Trial in Hachioji, Shinjuku-Ku (Tirzepatide, Placebo)
Completed
- Type 2 Diabetes Mellitus
- Tirzepatide
- Placebo
-
Hachioji, Tokyo, Japan
- +1 more
Jan 23, 2019
Type 2 Diabetes Trial in Worldwide (tirzepatide, Dulaglutide, Placebo)
Completed
- Type 2 Diabetes Mellitus
- tirzepatide
- +2 more
-
Mobile, Alabama
- +48 more
Jul 31, 2019
Type 2 Diabetes, Obesity Trial in Hellerup (Semaglutide 1.34 MG/ML [Ozempic], Glucose-dependent insulinotropic polypeptide
Recruiting
- Type 2 Diabetes
- Obesity
- Semaglutide 1.34 MG/ML [Ozempic]
- +3 more
-
Hellerup, Capital Region, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
May 19, 2022
Pancreatectomy; Hyperglycemia Trial in Hellerup (Intravenous infusion)
Not yet recruiting
- Pancreatectomy; Hyperglycemia
- Intravenous infusion
-
Hellerup, DenmarkClinical Metabolic Physiology
Dec 14, 2021
Healthy, Type 2 Diabetes (T2DM) Trial in South Miami, Singapore (LY3298176, Placebo, Dulaglutide)
Completed
- Healthy
- Type 2 Diabetes Mellitus (T2DM)
- LY3298176
- +2 more
-
South Miami, Florida
- +1 more
Jun 28, 2017